Press Releases Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Real-time Estimate Cboe BZX Other stock markets 08:04:26 13/05/2024 pm IST			5-day change	1st Jan Change
3.62 ^USD	+1.83%		-4.27%	-16.90%

25/03	Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target	MT
19/03	Alimera Sciences, Inc. Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences	07/05	AQ
Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update	30/04	AQ
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20/03	AQ
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	19/03	AQ
Alimera Sciences: Q4 Earnings Snapshot	07/03	AQ
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results	07/03	AQ
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update	29/02	AQ
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®	08/02	AQ
Alimera Completes Recruitment for the Synchronicity Study	04/01	AQ
Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	02/01	AQ
Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	12/12	AQ
Alimera Appoints Maggie A. Pax to Its Board of Directors	09/11	AQ
Alimera Announces Scientific Data Highlighting ILUVIEN® To Be Presented at the American Academy of Ophthalmology	31/23/31	AQ
Alimera Sciences: Q3 Earnings Snapshot	26/23/26	AQ
Alimera Sciences Reports Third Quarter 2023 Results	26/23/26	AQ
Alimera Sciences to Report Third Quarter 2023 Financial Results on October 26, 2023, and Provide Corporate Update	16/23/16	AQ
Alimera Announces Multiple Presentations Highlighting ILUVIEN® and YUTIQ® Data at Retina Society Annual Congress	11/23/11	AQ
Alimera Sciences Appoints Jason Werner as Chief Operating Officer	03/23/03	AQ
Alimera Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference	05/23/05	AQ
Alimera Sciences: Q2 Earnings Snapshot	10/23/10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Press Releases

Filters